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Pseudomyxoma peritonei is characterized by mucinous ascites originating from a mucin-producing neoplasm; however,
even the definition is still under debate. Tumor deposits extend and ultimately engulf the entire cavity, causing
death from cachexia due to limited intestinal movement. Here, we report a unique case of an 80-year-old woman
with pseudomyxoma peritonei, which extended to the lower extremity mimicking infectious condition. The patient
survived for a long time without bowel obstruction despite having the histologic subtype that has an unfavorable
prognosis. The extremity lesion was treated with limited extensive surgery. The origin of the disease and the mechanism
of extension to the extremity could not be clarified. Clinicians should be aware of the original disease entity and
this unusual presentation and determine its mechanism and the best management strategy.
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Pseudomyxoma peritonei (PMP) is a clinical syndrome
characterized by mucinous ascites that result from rup-
ture of a mucin-producing neoplasm [1–3]. However,
the origin, pathology, treatment, prognosis, and even the
very definition are still under debate [2]. While PMP is
currently thought to be associated mainly with neoplasm
of appendix [3–9], several convincing cases have demon-
strated other primary organs of origin such as the ovary,
urachus nest, and colon [10, 11]. In 1995, three distinct
categories of PMP were proposed on the basis of patho-
logical findings [10]. Recently, the paramount import-
ance of histopathological subtype in determining the
outcome was confirmed, and peritoneal mucinous car-
cinoma (PMCA) subtype was reported to be an inde-
pendent predictor of poorer overall survival based on a
large case series with long-term follow-up [12]. PMP
usually manifests as tumor deposits throughout the peri-
toneum [13]; it then engulfs the entire peritoneal cavity
and limits intestinal movement. Patients ultimately die
of cachexia if untreated [3, 14, 15].* Correspondence: ygchung@catholic.ac.kr
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creativecommons.org/publicdomain/zero/1.0/To the best of our knowledge, no case of PMP extension
to the lower extremity has ever been reported. Therefore,
the presentation, mechanism, and complications are un-
known, and the management strategy, including the appro-
priate surgical margin and adjuvant treatment for the
extremity lesion, are undetermined. In this paper, we share
our experience with this rare presentation.Case presentation
An 80-year-old woman presented to our institution with
odorous discharge from an opening in her swollen right
thigh. In the previous 4 years, her right thigh had swollen
up. Three months prior to her visit, an opening formed
spontaneously at the medial aspect of the thigh, and jelly-
like material began to ooze steadily. Two months before
her visit, an odorous discharge began to exude from the
opening. Physical examination revealed fluctuation in the
right lower quadrant of the abdomen, the medial aspect of
the right thigh, and the posterior aspect of the right calf.
Fourteen years previously, the patient had undergone an
operation for an intra-abdominal mass at another institu-
tion. The operation record mentioned a bilateral salpingo-
oophorectomy with massive adhesiolysis and excision of a
large 20 × 19 × 18-cm mass in the retroperitoneal space.
There was no mention of the appendix in the record, and
the patient had not undergone appendectomy before thele distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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borderline left ovarian tumor with extensive pseudomyx-
oma ovarii and severe tubo-ovarian adhesion. Although the
patient had noted progressive abdominal expansion with
dull pain in the right lower quadrant 8 years previously,
diagnostic studies such as computed tomography (CT) and
ultrasonography (US) [16] were not performed.
A magnetic resonance image of the right thigh showed
a fluid-containing lesion in contact with the surface and
an opening in the medial compartment. In addition,
there was a multiloculated, lobulated lesion mainly in-
volving the anterior and medial compartment of the
thigh and extending distally along the fascia of the ham-
string muscles (Fig 1a, b). A magnetic resonance image
of the calf also revealed a similar lesion chiefly involving
the posterior compartment along the deep fascia (Fig 1c, d).
An abdominal CT scan showed a large multiloculated cystic
mass occupying the right retroperitoneal space and
extending to the right thigh (Fig 1e). There were no
definite abnormal findings on the chest CT scan. To-
gether, these imaging studies revealed extension of the
lesion from the abdomen to the calf. The patient’s ini-
tial blood tests revealed abnormal results including aFig 1 Image findings. a A T2-weighted coronal view magnetic resonance i
the anterior compartment, especially the sartorius muscle (an arrowhead)
medial compartment along the fascia of the hamstring muscles (an arrow
multiloculated and lobulated lesions mainly involving the posterior compartme
superficial fascia (arrowheads). e A coronal view abdominal computed to
the right retroperitoneal space (arrowheads)white blood cell (WBC) count of 11,820/mm3, 87.5 %
segmented neutrophil, an erythrocyte sediment rate of
96 mm/h, 5.89 mg/dL C-reactive protein, 178 mg/dL
fasting blood sugar, 4.5 g/dL total protein, 2.4 g/dL al-
bumin, and 50 U/L aspartate transaminase. The urine
analysis and sediment examination noted abnormal re-
sults including leukocytosis, a positive occult blood,
and WBC and red blood cell count of 30 to 49 and 20
to 29 per high-power field.
Immediately after admission, we started intravenous
antibiotic administration, which included 2.25 g of piper-
acillin and tazobactam four times a day and 1 g vanco-
mycin once every 96 h. Two weeks after admission, a
suspected infected portion of the thigh lesion was ex-
cised, and tracks connecting from the thigh to the peri-
toneum were ligated. After the operation, administration
of 2.25 g of piperacillin and tazobactam four times a
day was continued. Staphylococcus epidermidis grew
when mucinous material obtained intra-operatively from
the lesion was cultured. Pathological examination of the
excised specimen demonstrated acellular mucinous ma-
terials with a carcinoembryonic antigen-positive immu-
noreaction (Fig 2a).mage (MRI) of the right thigh shows a cystic lesion mainly involving
. b A T2-weighted axial view MRI reveals lesions mainly involving the
head). c A T2-weighted coronal view of MRI of the right calf shows
nt (arrowheads). d A T2-weighted axial view MRI reveals a lesion along the
mography scan shows a large multiloculated cystic mass occupying
Fig 2 Pathologic findings. a Mucinous material obtained from the right thigh shows a carcinoembryonic antigen-positive immunoreaction
(carcinoembryonic antigen antibody stain, original magnification ×200). b A pathology slide demonstrates low-grade pseudomyxoma peritonei. The
malignant epithelium appears bland, and tumor cells look deceptively bland with papillary tufting (hematoxylin and eosin stain, original magnification
×200). c Dissecting mucin without tumor cells was observed in the soft tissue of the right thigh (hematoxylin and eosin stain, original magnification
×40). d A previous pathology slide demonstrates pseudomyxoma ovarii. The malignant epithelium appears bland, and tumor cells look deceptively
bland with papillary tufting
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sults demonstrated improvement of the infectious con-
dition in the thigh. The WBC count, segmented
neutrophil, erythrocyte sediment rate, C-reactive pro-
tein, fasting blood sugar, total protein, albumin, and as-
partate transaminase were 4640 /mm3, 51.8 %, 11 mm/h,
1.09 mg/dL, 112 mg/dL, 5.7 g/dL, 2.9 g/dL, and 24 U/L,
respectively. On urine analysis and sediment examination,
the WBC and red blood cell count were 1 to 3 and 4 to 9,
respectively, per high-power field.
A second operation was performed for all the lesions
from the abdomen to the calf by a collaborative team of
orthopedic surgeons and gynecologists. No bowel ob-
struction was observed, and the appendix was not seen.
A large volume of mucinous material was suctioned
from the abdominal lesion (Fig 3a). Multiple intra-
muscular and interfascial connections between the abdo-
men and lower extremity were observed at the level of the
inguinal ligament (Fig 3b). Cytoreductive surgery withperitonectomy was performed for the intra-abdominal
lesion. The lower extremity lesion was marginally removed;
it had a thin capsule and was mostly composed of mucin-
ous material (Fig 3c). Four hours after the operation, the
patient underwent cardiopulmonary resuscitation following
a hypovolemic shock due to massive intra-operative bleed-
ing. She recovered with proper management without any
acute sequelae.
Five days after the second surgery, no bacterial growth
was observed in a culture of intra-operatively obtained
mucinous material. Pathological examination showed
low-grade mucinous carcinoma peritonei with the lining
epithelium in the intra-abdominal lesion (Fig 2b) and
only acellular mucinous material in the lower extremity
lesion (Fig 2c). The patient’s postoperative course was
uneventful, and she was discharged 2 weeks after the
definitive operation. Thereafter, she sent us the pathology
slides from 14 years previously, which were re-
examined by pathologists at our institution. They
Fig 3 Intra-operative findings. a Mucus ascites is seen gushing from the abdominal lesion. b Multiple intra-muscular and interfascial connections
were observed at the level of the inguinal ligament. c A huge cystic lesion with mucus was observed in the calf
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did not report any abdominal symptoms or swelling in
the lower extremity at the most recent follow-up,
which was 2 years after the final operation. She was
able to walk with a cane, and the Musculoskeletal
Tumor Society functional rating for the lower extrem-
ity was 73 %.
Discussion
The origin of PMP is still controversial. PMP is currently
thought to be associated mainly with mucinous epithelial
neoplasms of the appendix [3–9]. However, several con-
vincing cases have been published with a different pri-
mary organ of origin, such as the ovary, urachus nest, or
colon [10, 11]. Because our patient had not undergone
an appendectomy before the operation in 1999 and there
was no mention on the appendix in the operation rec-
ord, we could not confirm the appendix as the origin of
PMP on histological grounds. Despite the previous
pathological report, the ovaries were normal and did not
appear to be the origin of the tumor based on the reviewof the previous slides. We, therefore, assume that the ap-
pendix was the organ of origin in this case.
PMP usually manifests with tumor deposits throughout
the entire peritoneal cavity. This characteristic pattern of
dissemination can be explained by the redistribution
phenomenon, which is associated with the intra-peritoneal
fluid current and gravity [13]. In the end stage of disease,
PMP engulfs the entire peritoneal cavity. Intestinal
movement becomes limited because of an excessive
amount of mucinous tumor mass, and bowel obstruc-
tion becomes imminent. Patients ultimately die of
cachexia when untreated [3, 14, 15].
CT and US have been reported to be useful in de-
tecting PMP [3, 17, 18]. While CT remains the gold
standard for diagnostic imaging, US is inexpensive,
readily available, well tolerated, and can identify most
common PMP findings such as ascites and omental
caking. Our patient did not have any diagnostic exam-
ination despite abdominal symptom, and a relapse was
diagnosed barely after development of the lower ex-
tremity lesion.
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egories of PMP, namely, diffuse peritoneal adenomucino-
sis (DPAM), PMCA, and an intermediate/discordant
subtype (PMCA-I/D) on the basis of pathological find-
ings. They reported that 5-year overall survival rates of
75 % in DPAM, 50 % in PMCA-I/D, and 14 % in PMCA
when the same surgeon treated PMP tumor patients uni-
formly. Recently, Chua et al. [12] examined the outcome
of nearly 2300 patients from 16 institutions worldwide
who were treated uniformly over an 18-year period and
confirmed the paramount importance of the histopatho-
logical subtype with respect to outcome. Five-year over-
all survival rates were 81 % for DPAM, 78 % for hybrid
tumors, and 59 % for PMCA. Multivariate analysis
showed that the PMCA subtype was an independent
predictor of poor overall survival.
Although the intra-peritoneal lesion in this case was
diagnosed as low-grade PMCA and optimal treatment
was not performed for a long time, our patient did not
report any symptoms associated with bowel obstruction.
Despite a huge lesion, her clinical course was modest
over a long period, and death by cachexia was avoided.
We assume that the extension of the intra-peritoneal
lesion to the lower extremity acted as an expansion of
the peritoneal cavity and prevented such an outcome.
When PMP is progressing, the characteristic visceral
and mesenteric sparing of PMP becomes visible intra-
operatively and is related to a favorable prognosis after
surgery [19], as in our case.
The proper treatment for PMP remains uncertain;
however, the combination of aggressive cytoreductive
surgery and hyperthermic intra-peritoneal chemotherapy
seems to improve the outcome [20]. Nevertheless, exten-
sive surgical resections to achieve complete tumor eradi-
cation are associated with high morbidity and mortality
rates and may decrease the quality of life without any
survival benefit, particularly in cases of extensive high-
grade diseases [21–23]. In contrast, less aggressive surgery
may be optimal in cases of extensive low-grade disease, as
in the extremity lesion of our patient if the benefit compen-
sates for surgical morbidity [24]. Chemotherapy may cause
side effects, particularly surgical complications, as a result
of bone marrow toxicity [25]. As in the case of peritoneal
lesions, we had to consider balancing treatment benefit and
morbidity in the extremity lesion. A wide excision encom-
passing large areas of muscle and parts of neurovascular
structures could have rendered the extremity nonfunc-
tional, especially with adjuvant treatments. In addition, it
may have caused more severe hypovolemia. Even if we had
chosen more aggressive management with careful support
from anesthesiologists, it would have been difficult to
achieve R0 margin because the mucinous contents and thin
capsule extended from the abdomen to the calf. The first
surgery had already contaminated the thigh area. Theadvanced age of the patient also added complexity; there-
fore, we performed less extensive surgery without any adju-
vant treatment for the extremity lesion.
Although the cause of PMP extension to the lower ex-
tremity has an important clinical significance, we could
not explain why the extension occurred only in this case.
The fluidity of mucinous contents and the gravity might
have contributed to the formation of the lower extremity
lesions as an extension of tuberculous psoas abscess into
the thigh. Further studies to elucidate the mechanism
are required.
Conclusions
We reported a rare case of PMP extension to the lower
extremity. Clinicians should understand the original dis-
ease entity of PMP, be aware of this unusual presentation
and complication, and determine the best management
strategy by balancing the benefits against possible mor-
bidity. We also expect further studies to elucidate the
mechanism of PMP extension to the lower extremity.
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